ESMO 2025: Precision medicine in bladder cancer

ESMO 2025: Bladder cancer highlights

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer

Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinoma

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC

Addition of radical prostatectomy to systemic treatment improves survival in oligometastatic prostate cancer

NeuroSAFE-guided RARP improves surgical precision for patients with localised prostate cancer

SIOG 2024: Updates in medical oncology

Robotic surgery for older patients with colorectal cancer shows positive outcomes